Thermal Energy International (TMG) Planet MicroCap Showcase: TORONTO 2025 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Showcase: TORONTO 2025 summary
23 Oct, 2025Business highlights and strategy
Consistent profitability for three years, with a focus on energy efficiency and carbon emission reduction for large multinationals.
Proprietary solutions deliver high ROI and significant repeat business, with 60%-70% of revenue from top 10 customers.
Revenue grew 41% over two years, reaching $30 million, with strong cash flow and nearly all debt repaid.
Record Q1 order intake and backlog, with $11.3 million in new orders and a $24.5 million backlog.
Strategic focus on expanding indirect sales channels, standardized products, and European manufacturing.
Technology and operational initiatives
Suite of 12 proprietary technologies, including Flu-Ace, GEM Steam Traps, Heat Sponge, and Rainmaker.
Crest mobile app launched to streamline sales, cross-sell, and reduce ramp-up time for new sales staff.
Crest app won Mobile App of the Year at the UK Technology Awards.
Outsourced manufacturing model for 80%-90% of products, with plans to expand Heat Sponge production in Europe.
Indirect sales network to drive higher-margin equipment sales and free internal teams for strategic projects.
Market opportunity and customer base
Focus on large, energy-intensive multinationals, especially in food & beverage (60%) and pharma (20%).
Less than 5% penetration at existing customer sites, indicating significant growth potential.
Global opportunity, with current strategic focus on Europe and North America.
Projects deliver 20%+ IRR, with strong customer retention and multiple projects per client.
Sales cycle for large projects is typically 12 months, with most revenue recognized in the latter half.
Latest events from Thermal Energy International
- Record revenue, surging profits, and a robust order backlog signal strong growth momentum.TMG
Q2 20262 Feb 2026 - Record revenue, EBITDA, and order backlog signal strong growth and future momentum.TMG
Q4 202420 Jan 2026 - Record revenue, rising backlog, and growth investments support a strong outlook.TMG
Q1 202517 Jan 2026 - Record revenue and strong backlog highlight growth, despite margin and profit pressure.TMG
Q2 20259 Jan 2026 - Record revenue and strong backlog position for future profitability gains.TMG
Q3 202525 Nov 2025 - Record Q1 order intake and backlog, pharma growth, and debt reduction drive strong outlook.TMG
Q1 202629 Oct 2025 - Record revenue, margin gains, and a $24.3M backlog drive strong growth for H2 2026.TMG
Q4 202523 Sep 2025